These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 23151827

  • 1. Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity.
    Amlien IK, Fjell AM, Walhovd KB, Selnes P, Stenset V, Grambaite R, Bjørnerud A, Due-Tønnessen P, Skinningsrud A, Gjerstad L, Reinvang I, Fladby T.
    Radiology; 2013 Jan; 266(1):295-303. PubMed ID: 23151827
    [Abstract] [Full Text] [Related]

  • 2. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X, Li TQ, Andreasen N, Wiberg MK, Westman E, Wahlund LO.
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [Abstract] [Full Text] [Related]

  • 3. Cingulum fiber diffusivity and CSF T-tau in patients with subjective and mild cognitive impairment.
    Stenset V, Bjørnerud A, Fjell AM, Walhovd KB, Hofoss D, Due-Tønnessen P, Gjerstad L, Fladby T.
    Neurobiol Aging; 2011 Apr; 32(4):581-9. PubMed ID: 19428143
    [Abstract] [Full Text] [Related]

  • 4. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M, Yadav SK, Rizwan A, Singh A, Cai K, Kaura D, Wang E, Davatzikos C, Trojanowski JQ, Melhem ER, Marincola FM, Borthakur A.
    Neuroimage Clin; 2015 Apr; 7():598-604. PubMed ID: 25844314
    [Abstract] [Full Text] [Related]

  • 5. White matter diffusivity predicts memory in patients with subjective and mild cognitive impairment and normal CSF total tau levels.
    Grambaite R, Stenset V, Reinvang I, Walhovd KB, Fjell AM, Fladby T.
    J Int Neuropsychol Soc; 2010 Jan; 16(1):58-69. PubMed ID: 19835655
    [Abstract] [Full Text] [Related]

  • 6. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment.
    Selnes P, Aarsland D, Bjørnerud A, Gjerstad L, Wallin A, Hessen E, Reinvang I, Grambaite R, Auning E, Kjærvik VK, Due-Tønnessen P, Stenset V, Fladby T.
    J Alzheimers Dis; 2013 Jan; 33(3):723-36. PubMed ID: 23186987
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal changes of CSF biomarkers in Alzheimer's disease.
    Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK.
    J Alzheimers Dis; 2011 Jan; 25(4):583-94. PubMed ID: 21460434
    [Abstract] [Full Text] [Related]

  • 8. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.
    Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O.
    Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792
    [Abstract] [Full Text] [Related]

  • 9. Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.
    Kester MI, Teunissen CE, Crimmins DL, Herries EM, Ladenson JH, Scheltens P, van der Flier WM, Morris JC, Holtzman DM, Fagan AM.
    JAMA Neurol; 2015 Nov; 72(11):1275-80. PubMed ID: 26366630
    [Abstract] [Full Text] [Related]

  • 10. Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease.
    Agosta F, Dalla Libera D, Spinelli EG, Finardi A, Canu E, Bergami A, Bocchio Chiavetto L, Baronio M, Comi G, Martino G, Matteoli M, Magnani G, Verderio C, Furlan R.
    Ann Neurol; 2014 Dec; 76(6):813-25. PubMed ID: 25087695
    [Abstract] [Full Text] [Related]

  • 11. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M.
    J Alzheimers Dis; 2015 Dec; 44(2):625-33. PubMed ID: 25322924
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
    Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD.
    J Alzheimers Dis; 2015 Dec; 44(2):525-39. PubMed ID: 25391385
    [Abstract] [Full Text] [Related]

  • 13. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
    Parnetti L, Chiasserini D, Eusebi P, Giannandrea D, Bellomo G, De Carlo C, Padiglioni C, Mastrocola S, Lisetti V, Calabresi P.
    J Alzheimers Dis; 2012 Dec; 29(1):229-38. PubMed ID: 22232006
    [Abstract] [Full Text] [Related]

  • 14. White matter imaging changes in subjective and mild cognitive impairment.
    Selnes P, Fjell AM, Gjerstad L, Bjørnerud A, Wallin A, Due-Tønnessen P, Grambaite R, Stenset V, Fladby T.
    Alzheimers Dement; 2012 Oct; 8(5 Suppl):S112-21. PubMed ID: 23021621
    [Abstract] [Full Text] [Related]

  • 15. White matter integrity in mild cognitive impairment: a tract-based spatial statistics study.
    Zhuang L, Wen W, Zhu W, Trollor J, Kochan N, Crawford J, Reppermund S, Brodaty H, Sachdev P.
    Neuroimage; 2010 Oct 15; 53(1):16-25. PubMed ID: 20595067
    [Abstract] [Full Text] [Related]

  • 16. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance.
    Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junqué C, Solé-Padullés C, Peña-Gómez C, Bargalló N, Molinuevo JL, Bartrés-Faz D.
    Neurobiol Aging; 2012 Jan 15; 33(1):61-74. PubMed ID: 20371138
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
    Mattsson N, Portelius E, Rolstad S, Gustavsson M, Andreasson U, Stridsberg M, Wallin A, Blennow K, Zetterberg H.
    J Alzheimers Dis; 2012 Jan 15; 30(4):767-78. PubMed ID: 22475796
    [Abstract] [Full Text] [Related]

  • 18. Specific anatomic associations between white matter integrity and cognitive reserve in normal and cognitively impaired elders.
    Arenaza-Urquijo EM, Bosch B, Sala-Llonch R, Solé-Padullés C, Junqué C, Fernández-Espejo D, Bargalló N, Rami L, Molinuevo JL, Bartrés-Faz D.
    Am J Geriatr Psychiatry; 2011 Jan 15; 19(1):33-42. PubMed ID: 20808130
    [Abstract] [Full Text] [Related]

  • 19. Correlations between microstructural alterations and severity of cognitive deficiency in Alzheimer's disease and mild cognitive impairment: a diffusional kurtosis imaging study.
    Gong NJ, Wong CS, Chan CC, Leung LM, Chu YC.
    Magn Reson Imaging; 2013 Jun 15; 31(5):688-94. PubMed ID: 23347602
    [Abstract] [Full Text] [Related]

  • 20. Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study.
    Shu N, Wang Z, Qi Z, Li K, He Y.
    J Alzheimers Dis; 2011 Jun 15; 26 Suppl 3():275-85. PubMed ID: 21971467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.